MANSFIELD, MASSACHUSETTS-February 18, 2020- Allevi and Mansfield Bio-Incubator signed an agreement to promote the 3D bioprinting technology in the start-up community.
Mansfield Bio-Incubator is a non-profit biotech, pharma, life science, and medical device business incubator facility. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech, pharma, life science, and medical device companies. We were created to nurture entrepreneurial and economic development in the community. We aim to do this by maintaining affordable lab and office space and making cutting-edge technology, services, training, mentoring, and a network of professional advisors available to small biotechnology companies and healthcare-related start-ups.
Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters and bioinks are used around the world to find solutions to humanity’s most difficult problems – to cure disease, to test novel drugs, and to eliminate the organ transplant waiting list.
Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinters to be the most versatile, powerful and easy-to-use bioprinters on the market. Allevi is trusted by leading researchers and industry giants in hundreds of labs globally in the fields of tissue engineering, organ-on-a-chip research, pharmaceutical validation, biomaterial development, and regenerative medicine.
This Confidential agreement aims to create the conditions for a partnership cooperation between the between the two parties